Research ArticleImmunologyInfectious disease Free access | 10.1172/jci.insight.90652
1Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, and
2Department of Immunology, Duke University Medical Center, Durham, North Carolina, USA.
Address correspondence to: Yiping Yang or Xiaopei Huang, Department of Medicine, Duke University Medical Center, Box 103005, Durham, North Carolina 27710, USA. Phone: 919.668.0932; E-mail: yang0029@mc.duke.edu (Y. Yang). Phone: 919.668.0979; E-mail: huang027@mc.duke.edu (X. Huang).
Find articles by Yuan, Y. in: JCI | PubMed | Google Scholar
1Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, and
2Department of Immunology, Duke University Medical Center, Durham, North Carolina, USA.
Address correspondence to: Yiping Yang or Xiaopei Huang, Department of Medicine, Duke University Medical Center, Box 103005, Durham, North Carolina 27710, USA. Phone: 919.668.0932; E-mail: yang0029@mc.duke.edu (Y. Yang). Phone: 919.668.0979; E-mail: huang027@mc.duke.edu (X. Huang).
Find articles by Yang, Y. in: JCI | PubMed | Google Scholar
1Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, and
2Department of Immunology, Duke University Medical Center, Durham, North Carolina, USA.
Address correspondence to: Yiping Yang or Xiaopei Huang, Department of Medicine, Duke University Medical Center, Box 103005, Durham, North Carolina 27710, USA. Phone: 919.668.0932; E-mail: yang0029@mc.duke.edu (Y. Yang). Phone: 919.668.0979; E-mail: huang027@mc.duke.edu (X. Huang).
Find articles by Huang, X. in: JCI | PubMed | Google Scholar
Published April 6, 2017 - More info
IL-21 has been shown to play an important role in the CD8 T cell response during acute and chronic viral infections. However, the role of IL-21 signaling in the CD4 T cell response to viral infection remains incompletely defined. In a model of infection with vaccinia virus, we show that intrinsic IL-21 signaling on CD4 T cells was critical for the formation of memory CD4 T cells in vivo. We further reveal that IL-21 promoted CD4 T cell survival in a mechanism dependent on activation of the STAT1 and STAT3 signaling pathways. In addition, the activation of Akt is also required for IL-21–dependent survival of CD4 T cells in vivo. These results identify a critical role for intrinsic IL-21 signaling in CD4 T cell survival and memory formation in response to viral infection in vivo and may provide insights into the design of effective vaccine strategies.
IL-21, which is produced mainly by activated CD4 T cells (1) and NKT cells (2), is a member of the common-γ chain family of cytokines that includes IL-2, IL-4, IL-7, IL-9, and IL-15 (1, 3). Previous studies have shown that IL-21 plays an important role in the regulation of both innate and adaptive immune responses (3). IL-21 is critical for NK cell activation and expansion (1, 4). IL-21 also promotes terminal B cell differentiation into plasma cells and antibody production (5, 6). Furthermore, IL-21 enhances antigen-specific CD8 T cell expansion (7) and the differentiation of follicular helper T cells in vivo (8). IL-21 also promotes the differentiation of the inflammatory Th17 lineage (9, 10) and contributes to autoimmunity (3). In addition, it has been shown that direct action of IL-21 on CD8 T cells is required to sustain the CD8 T cell response during chronic viral infections (11–13).
Recent studies have shown that IL-21 signaling is also critical for the formation of memory CD8 T cells in response to acute viral infections (14–16). This is achieved by promoting the survival of effector CD8 T cells in a STAT1- and STAT3-dependent manner (14). Although IL-21 is mainly produced by activated CD4 T cells (1), it remains to be determined whether IL-21 signaling is also required for the formation of memory CD4 T cells following an acute viral infection.
In this study, we show that direct IL-21 signaling on CD4 T cells was also required for the formation of memory CD4 T cells in response to infection with vaccinia virus (VV) in vivo. We further found that the activation, proliferation, or effector differentiation of CD4 T cells in response to VV infection in vivo was not affected by lack of IL-21 signaling. However, the survival of activated CD4 T cells was critically dependent on direct IL-21 signaling on CD4 T cells. In addition, we found in vitro that IL-21 signaling promoted CD4 T cell survival by activating the STAT1 and STAT3 signaling pathways. In vivo, CD4 T cells defective for IL-21 signaling had reduced levels of STAT1 and STAT3 activation in response to VV infection. We further demonstrated that the activation of Akt in CD4 T cells was compromised in the absence of IL-21 signaling and that the IL-21/Akt pathway was critical for CD4 T cell survival in vivo. Altogether, our study indicates that direct IL-21 signaling is required for the survival of activated CD4 T cells and the formation of long-lived memory cells in response to VV infection.
Intrinsic IL-21 signaling is required for CD4 memory formation in vivo. To study whether IL-21 signaling is required for the formation of memory CD4 T cells in response to VV infection, naive WT or IL-21R–/– influenza HA-specific CD4 T cells (Thy1.2+) derived from 6.5 TCR-HA transgenic mice were transferred into congenic Thy1.1+ mice that were subsequently infected with recombinant VV encoding HA (VV-HA). At different time points after infection, splenocytes were analyzed for the presence of the clonotypic CD4 T cells. Seven days after infection, a similar degree of clonal expansion was observed for both the WT and IL-21R–/– HA-specific CD4 T cells (Figure 1, A, and B). Thereafter, WT HA-specific CD4 T cells underwent contraction to form a memory pool (Figure 1, A and B), whereas IL-21R–/– HA-specific CD4 T cells could not survive the contraction phase to develop into memory cells (Figure 1, A and B). To ensure that the lack of memory formation with IL-21R–/– HA-specific T cells was not due to a low sensitivity of detection in our system, we boosted mice at day 42 with recombinant adenovirus encoding HA (Ad-HA) to assess the recall response. We observed a robust recall expansion of WT HA-specific memory CD4 T cells (Figure 1C). However, there were still no detectable IL-21R–/– HA-specific CD4 T cells (Figure 1C).
Lack of IL-21 signaling in HA-specific CD4 T cells leads to defective CD4 memory formation in the response to VV infection. 5 × 104 naive clonotypic HA-specific CD4 T cells (Thy1.2+) sorted from WT or IL-21R–/– TCR-HA transgenic mice were transferred into Thy1.1+ mice intravenously, followed by infection with 5 × 106 pfu VV-HA i.p., or left uninfected as naive controls. 7, 14, 28, and 42 days after infection, splenocytes were harvested and stained with anti-CD4 and anti-Thy1.2. (A) FACS plots with percentages of total clonotypic CD4 T cells among total CD4 T cells. (B) Mean absolute numbers ± SEM of clonotypic CD4 T cells per spleen (n = 4 per group). (C) At day 42, some mice were rechallenged with Ad-HA (2 × 109 pfu) intravenously and harvested 5 days later (day 42+5) for recall responses. Mean absolute numbers ± SEM of clonotypic CD4 T cells per spleen before (day 42) and after (day 42 + 5) rechallenge with Ad-HA are indicated (n = 4 per group). Data are representative of 3 independent experiments.
To further test that the importance of IL-21 in the CD4 T cell memory response to viral infection is not just restricted to a particular T cell receptor (TCR), we repeated the experiments with OVA-specific CD4 T cells derived from DO.11 TCR-OVA transgenic mice. Indeed, we showed that, similar to HA-specific T cells (Figure 1, A and B), IL-21R–/– OVA-specific CD4 T cells could not develop into memory cells (Figure 2, A and B), suggesting that the role of IL-21 in CD4 memory formation is not restricted to a single TCR. However, in contrast to HA-specific T cells, we found that IL-21 deficiency in OVA transgenic T cells led to a reduction in clonal expansion at day 7 (Figure 2A). To further confirm this observation, WT (Thy1.2+) and IL-21R–/– (Thy1.1+) OVA-specific CD4 T cells were mixed at a 1:1 ratio and cotransferred into congenic mice that were subsequently infected with VV encoding OVA (VV-OVA). Seven and twenty-one days after infection, splenocytes were analyzed for the presence of WT (Thy1.2+) versus IL-21R–/– (Thy1.1+) OVA-specific CD4 T cells. Indeed, the clonal expansion of IL-21R–/– OVA-specific CD4 T cells at day 7 was significantly (P < 0.05) reduced compared with the WT counterparts, leading to no detectable memory cells by day 21 (Figure 2, C and D). The reason for the differential clonal expansion between two different clonotypic T cells remains unclear but could be related to reduced proliferation and/or increased apoptosis in OVA-specific CD4 T cells compared with the HA-specific T cells. Nevertheless, these data further support our observation that intrinsic IL-21 signaling in CD4 T cells is critical for the formation of long-lived memory cells in response to VV infection.
IL-21–deficient OVA-specific CD4 T cells fail to develop memory response to VV infection. (A and B) 1 × 105 naive OVA-specific CD4 T cells (Thy1.1+) sorted from WT or IL-21R–/– OVA-transgenic mice were transferred into Thy1.2+ mice intravenously, followed by infection with 5 × 106 pfu VV-OVA i.p., or were left uninfected as naive controls. 7, 14, 28, and 42 days after the infection, splenocytes were stained with anti-CD4 and anti-Thy1.1. (A) Mean absolute numbers ± SEM of clonotypic CD4 T cells per spleen (n = 4 per group). At day 42, some mice were rechallenged with Ad-OVA (2 × 109 pfu) intravenously and harvested 5 days later (day 42+5) for recall responses. (B) Mean absolute numbers ± SEM of clonotypic CD4 T cells per spleen before (day 42) and after (day 42+5) rechallenge with Ad-OVA (n = 4 per group). (C and D) WT (Thy1.2+) and IL-21R–/– (Thy1.1+) OVA-specific CD4 T cells (5 × 105) were mixed at 1:1 ratio and cotransferred into Thy1.1+ congenic mice, followed by infection with 5 × 106 pfu VV-OVA. 7 and 21 days after infection, splenocytes were stained with anti-CD4, anti-Thy1.1, anti-Thy1.2, and anti-DO.11 OVA-TCR (KJ1-26) and analyzed for the presence of WT (Thy1.2+) versus IL-21R–/– (Thy1.1+) OVA-specific CD4 T cells. (C) FACS plots with percentages of WT (Thy1.2+) and IL-21R–/– (Thy1.1+) OVA-specific CD4 T cells among total clonotypic CD4 T cells. (D) Mean absolute numbers ± SEM of WT (Thy1.2+) and IL-21R–/– (Thy1.1+) OVA-specific CD4 T cells per spleen (n = 4 per group). Data are representative of 3 independent experiments.
IL-21 signaling is critical for the survival of activated CD4 T cells in vivo. Lack of CD4 memory formation in the absence of intrinsic IL-21 signaling could be due to insufficient activation, proliferation, or effector differentiation or poor survival. To address these possibilities, we transferred naive WT or IL-21R–/– HA-specific CD4 T cells (Thy1.2+) into congenic Thy1.1+ mice and subsequently infected the hosts with VV-HA. Twenty-four hours after infection, both WT and IL-21R–/– clonotypic CD4 T cells displayed a similarly activated CD44hiCD69hi phenotype compared with the naive CD44loCD69lo phenotype (Figure 3, A and B), suggesting that the activation of CD4 T cells early during infection is not affected by lack of IL-21 signaling. Three days after infection, CFSE-labeled WT and IL-21R–/– clonotypic CD4 T cells underwent similar levels of proliferation, as measured by CFSE dilution (Figure 3C), suggesting that lack of IL-21 signaling does not affect CD4 T cell proliferation in vivo. Furthermore, IL-21R–/– clonotypic CD4 T cells produced similar levels of IFN-γ (P > 0.05), further confirming that activation of clonotypic CD4 T cells is not affected in the absence of IL-21 signaling (Figure 3, D and E).
The activation of CD4 T cells is independent of IL-21 signaling. 5 × 105 purified naive clonotypic CD4 T cells from WT or IL-21R–/– TCR-HA transgenic mice (Thy1.2+) were transferred into Thy1.1+ congenic recipients that were subsequently infected with VV-HA (5 × 106 pfu, i.p., +VV). Some mice were left uninfected (Naive). (A and B) Twenty-four hours after infection, splenocytes were harvested and stained with antibodies to CD4, Thy1.2, and the activation markers CD44 or CD69. (A) FACS plots and the percentages of CD44hi and CD69hi. (B) Mean absolute numbers ± SEM of CD44hi and CD69hi (n = 4 per group). (C) Three days after infection, in vivo division of CFSE-labeled clonotypic cells in the spleen was analyzed, and the percentages of CFSE-positive cells are shown. (D and E) Seven days after infection, splenocytes were stained with anti-CD4, anti-Thy1.2, and anti–IFN-γ intracellularly. (D) FACS plots and the percentages of IFN-γ–producing clonotypic cells. (E) Mean absolute numbers ± SEM of IFN-γ–producing clonotypic cells among clonotypic CD4 T cells (n = 4 per group). Data shown are representative of 3 independent experiments.
We next determined whether the lack of memory formation in IL-21R–/– CD4 T cells was due to enhanced apoptosis in the absence of IL-21 signaling. We transferred naive WT or IL-21R–/– HA-specific CD4 T cells into naive hosts that were subsequently infected with VV-HA. Seven days later, splenocytes were stained with annexin V to detect cells undergoing apoptosis. Indeed, IL-21R–/– clonotypic CD4 T cells had a significant (P < 0.05) increase in annexin V compared with WT clonotypic cells (Figure 4, A and B). This is correlated with a significant (P < 0.05) reduction in the expression of the prosurvival factor, Bcl-xL, in IL-21R–/– clonotypic CD4 T cells compared with the WT control (Figure 4, C and D). These results suggest that the survival of activated CD4 T cells is critically dependent on intrinsic IL-21 signaling in vivo.
IL-21 signaling is required for the survival of activated CD4 T cells. 5 × 105 purified naive clonotypic CD4 T cells from WT or IL-21R–/– TCR-HA transgenic mice (Thy1.2+) were transferred into Thy1.1+ congenic recipients that were subsequently infected with VV-HA (+VV). Some mice were left uninfected (Naive). Seven days after infection, splenocytes were stained with (A) anti-CD4, anti-Thy1.2, and annexin V or (C) Bcl-XL. The mean percentages ± SEM of (B) annexin V+ and (D) Bcl-XL+ clonotypic CD4 T cells are indicated (n = 4 per group). All plots are gated on CD4+Thy1.2+ cells. Data shown are representative of 3 independent experiments.
IL-21–dependent survival of activated CD4 T cells is mediated by STAT1 and STAT3. We next sought to investigate how intrinsic IL-21 signaling promotes the survival of CD4 T cells. It has been shown that IL-21–dependent CD8 T cell survival is mediated by the STAT1 and STAT3 pathways (14). To study whether these STAT pathways also play a role in IL-21–mediated CD4 T cell survival, we first cultured naive polyclonal CD4 T cells in the presence of recombinant IL-21 and assessed the activation of STAT1 and STAT3 by intracellular staining for phosphorylated STAT1 (pSTAT1) and phosphorylated STAT3 (pSTAT3). Increased activation of both STAT1 and STAT3 was observed in cultures supplemented with IL-21, compared with the medium-only control (P < 0.05) (Figure 5, A and B).
IL-21 signaling promotes activation of STAT1 and STAT3. (A and B) Purified polyclonal CD4 T cells were cultured for 1 hour in medium alone (Medium) or medium supplemented with recombinant murine IL-21 (+ IL21). (A) Cells were stained with anti-STAT1, anti-pSTAT1, anti-STAT3, or anti-pSTAT3 intracellularly. (B) Mean percentages ± SEM of STAT1-, pSTAT1-, STAT3-, or pSTAT3-positive cells (n = 4 per group). (C and D) 5 × 105 purified naive clonotypic CD4 T cells from WT or IL-21R–/– TCR-HA transgenic mice (Thy1.2+) were transferred to Thy1.1+ congenic recipients that were subsequently infected with VV-HA (5 × 106 pfu). Some mice were left uninfected (Naive). (C) Seven days after infection, splenocytes were stained with anti-CD4 and anti-Thy1.2 as well as anti-pSTAT1, anti-pSTAT3, anti-STAT1, anti-STAT3, or an isotype control intracellularly. (D) Mean percentages ± SEM of pSTAT1+ and pSTAT3+ among clonotypic CD4 T cells (n = 4 per group). Data are representative of 3 independent experiments.
We then examined whether IL-21 signaling on CD4 T cells promotes activation of STAT1 and STAT3 upon VV infection in vivo. Naive WT or IL-21R–/– HA-specific CD4 T cells were transferred into congenic mice that were subsequently infected with VV-HA. Five days after infection, splenocytes were harvested and stained intracellularly for pSTAT1 and pSTAT3. Significant (P < 0.05) activation of both STAT1 and STAT3 was observed in WT clonotypic CD4 T cells upon VV infection in vivo, compared with the naive control (Figure 5, C and D). However, the extent of STAT1 and STAT3 activation was significantly (P < 0.05) reduced in IL-21R–/– clonotypic CD4 T cells, compared with their WT counterparts (Figure 5, C and D). This reduction was not due to a decreased level of total STAT1 or STAT3 in IL-21R–/– cells (Figure 5, C and D). These results indicate that intrinsic IL-21 signaling in CD4 T cells is required for efficient activation of STAT1 and STAT3.
To further determine whether the STAT1 and STAT3 pathways were required for IL-21–dependent CD4 T cell survival, naive WT or STAT1–/– polyclonal CD4 T cells were retrovirally transduced with either empty vector or a STAT3 dominant-negative (STAT3-DN) vector and cultured in the presence of IL-21. We observed that CD4 T cell apoptosis was significantly (P < 0.05) reduced when WT cells with empty vector were cultured in the presence of IL-21 compared with WT cells with the medium alone (Figure 6). However, this inhibition of apoptosis by IL-21 was abrogated in the absence of STAT1 (Figure 6), suggesting that STAT1 is critical for IL-21–dependent CD4 T cell survival. In addition, WT cells transduced with STAT3-DN also showed a reduction in IL-21–induced inhibition of apoptosis (Figure 6). Collectively, these data suggest that IL-21–dependent CD4 T cell survival is mediated by both the STAT1 and STAT3 pathways.
IL-21–mediated CD4 T cell survival is dependent on STAT1 and STAT3. Purified polyclonal CD4+ T cells from WT or STAT1–/– mice were stimulated with PMA (40 ng/ml) and ionomycin (500 ng/ml) in the presence of IL-2 (100 U/ml) for 24 hours and then retrovirally infected with empty vector or dominant-negative STAT3 vector (STAT3-DN) by spin infection. (A) Treated cells cultured in medium alone (medium) or in medium supplemented with IL-21 (+ IL21) for 4 more days were stained with annexin V. (B) Mean percentages ± SEM of annexin V+ cells (n = 4 per group). Data shown are representative of 3 independent experiments.
The activation of Akt is also required for IL-21–dependent CD4 T cell survival. In addition to the STAT1 and STAT3 pathways, the PI3K/Akt pathway has also been implicated in promoting IL-21–mediated T cell survival in vitro (17). To test whether the PI3K/Akt pathway is also important in promoting CD4 T cell survival in response to VV infection in vivo, we compared the activation of Akt in WT versus IL-21R–/– HA-specific CD4 T cells upon VV infection. Naive WT or IL-21R–/– clonotypic CD4 T cells were transferred into congenic mice that were subsequently infected with VV-HA. Five days after infection, splenocytes were harvested and stained intracellularly for pAkt. Marked activation of Akt was observed in WT clonotypic CD4 T cells, compared with the naive control (Figure 7). However, the extent of Akt activation was significantly (P < 0.05) reduced in IL-21R–/– clonotypic CD4 T cells, compared with their WT counterparts (Figure 7), suggesting that intrinsic IL-21 signaling in CD4 T cells is also important for efficient activation of Akt.
IL-21 signaling also promotes activation of Akt in vivo. 1 × 106 purified naive clonotypic HA-specific CD4 T cells from WT or IL-21R–/– TCR-HA transgenic mice (Thy1.2+) were transferred into Thy1.1+ congenic recipients that were subsequently infected with VV-HA (5 × 106 pfu). (A) Some mice were left uninfected (Naive). Five days after infection, splenocytes were stained with anti-CD4 and anti-Thy1.2 as well as anti-Akt or anti-pAkt or an isotype control intracellularly. (B) Mean percentages ± SEM of Akt+ and pAkt+ among clonotypic CD4 T cells (n = 4 per group). Data are representative of 3 independent experiments.
To further examine the role of the Akt pathway in IL-21–mediated CD4 T cell survival in vivo, we first tested whether WT clonotypic CD4 T cells transduced with an Akt dominant-negative retrovirus (DN Akt) had a reduced survival upon VV infection. Seven and fifteen days after infection, a significant reduction in the percentage as well as the absolute cell numbers of the DN Akt–transduced CD4 T cells was observed, compared with the empty vector–transduced WT cells (P < 0.05) (Figure 8). We then tested whether the reduced survival of IL-21R–/– clonotypic CD4 T cells upon VV infection could be rescued by transduction with a constitutive activated form of Akt (constitutive Akt). Indeed, the transduction of constitutive Akt promoted the survival of IL-21R–/– CD4 T cells (P < 0.05) (Figure 8).
Akt is required for IL-21–dependent CD4 T cell survival in vivo. Purified naive clonotypic HA-specific CD4 T cells from WT or IL-21R–/– TCR-HA transgenic mice were stimulated with 40 ng/ml PMA and 500 ng/ml ionomycin for 24 hours in vitro. Stimulated cells were then infected with retrovirus-encoding dominant-negative (DN) Akt or constitutively activated (constitutive) Akt. The retroviral vectors carried GFP. Thus, the GFP+ cells after infection were selected by sorting. 5 × 104 GFP+ WT or IL21R–/– HA-specific T cells were transferred into Thy1.1 mice intravenously. Recipient mice were subsequently infected with 5 × 106 pfu VV by i.p. injection. Splenocytes were harvested for analysis 7 and 15 days after infection. (A) The percentage of GFP+Thy1.2+CD4+ cells among total CD4+ T cells. (B) The mean absolute numbers ± SEM of GFP+Thy1.2+CD4+ cells per spleen (n = 4 per group). Data are representative of 3 independent experiments.
Taken together, these results suggest that the activation of Akt is also critical for IL-21–dependent CD4 T cell survival in response to VV infection in vivo.
In this study, we demonstrate that IL-21 signaling on CD4 T cells is critical for the formation of memory CD4 T cells in response to VV infection. This is achieved by promoting the survival of activated CD4 T cells in a STAT1- and STAT3-dependent manner. We further reveal that activation of Akt is also required for IL-21–dependent survival of CD4 T cells in vivo.
What is responsible for the generation and maintenance of the memory T cell population remains incompletely defined. Studies have shown that inflammatory signals (18) and the nature and the strength of TCR stimulation (19–21) as well as the costimulation (22) can promote the formation of memory T cells. In addition, the common-γ chain cytokines IL-7 and IL-15 are also critical in the maintenance of memory T cells (23, 24). Although IL-21 has been shown to be important for the formation of memory CD8 T cells in response to acute viral infections (14–16), its role in CD4 T cell responses remains unclear. In a model of VV infection, here we provided evidence that IL-21 signaling is also required for the formation of memory CD4 T cells following an acute viral infection in vivo.
Previous studies have shown that IL-21 signaling in CD8 T cells can preferentially activate the STAT1 and STAT3 pathways, leading to enhanced T cell proliferation in combination with IL-15 in vitro (25) and CD8 T cell survival and memory formation in vivo (26). Here, we show that IL-21 signaling also activates both STAT1 and STAT3 pathways in CD4 T cells in vitro and that IL-21 enhances the survival of anti-CD3-activated CD4 T cells in a STAT1- and STAT3-dependent manner. In addition to the STAT1 and STAT3 pathways, the PI3K/Akt pathway has been shown to promote IL-21–mediated T cell survival in vitro (17). Indeed, we demonstrated in this study that the activation of Akt is also critical for IL-21–dependent CD4 T cell survival in response to VV infection in vivo. It remains to be determined in the future whether the STAT1/STAT3 and Akt pathways interact and coordinate to promote CD4 T cell survival.
In conclusion, we have shown that direct action of IL-21 on CD4 T cells is required for the formation of memory CD4 T cells in response to VV infection in vivo through promotion of the survival of activated CD4 T cells. This IL-21–dependent CD4 T cell survival is mediated through the STAT1 and STAT3 signaling pathways. In addition, the activation of Akt is also required for IL-21–dependent survival of CD4 T cells in vivo. These results identify a critical role for intrinsic IL-21 signaling in CD4 T cell survival and memory formation in response to viral infection in vivo and may provide insights into the design of effective vaccine strategies.
Mice. B10.D2 and 129/Sv mice were purchased from The Jackson Laboratory and Charles River Laboratories, respectively. IL-21R–/– mice on a BALB/c background were a gift from W.J. Leonard (NIH, Bethesda, Maryland, USA) (5) and were backcrossed to the B10.D2 background for 9 generations. STAT1–/– mice on the 129/Sv background were purchased from Taconic. The 6.5 TCR-HA transgenic mice that express a TCR recognizing an I-Ed–restricted HA epitope (110SFERFEIFPKE120) were provided by H. von Boehmer (Harvard University, Boston, Massachusetts, USA) (27). The DO.11 TCR-OVA transgenic mice in BALB/c background that express a TCR recognizing an I-Ad–restricted OVA epitope (323ISQAVHAAHAEINEAGR339) were purchased from The Jackson Laboratory (28).
TCR-HA and TCR-OVA transgenic mice were backcrossed to the B10.D2 background and then intercrossed with IL21R–/– mice to generate IL-21R–/– TCR-HA and TCR-OVA mice for the study. All mice used for experiments were between 8 and 10 weeks of age.
Viruses and in vivo immunization. Recombinant VV-HA and recombinant E1-deleted Ad-HA were previously described (29). Recombinant VV-OVA was provided by Jonathan Yewdell at NIH. Recombinant adenovirus encoding OVA (Ad-lacZ) was generated by homologous recombination in E. coli as described previously (30). VV-HA or VV-OVA was grown in TK-143B cells, purified by sucrose banding, and titer was determined by plaque-forming assay on TK-143B cells. Mice were infected with 5 × 106 pfu i.p. Ad-HA or Ad-OVA was grown in 293 cells (ATCC), purified by 2 rounds of CsCl density centrifugation, and desalted by gel filtration through a Sephadex G-25 column (PD-10 column, Amersham Bioscience). The titer was determined by plaque-forming assay on 293 cells. Mice were infected with 2 × 109 pfu i.p.
Adoptive transfer of T cells. Naive clonotypic HA-specific (or OVA-specific) CD4 T cells were prepared from WT and IL-21R–/– 6.5 (or DO11) TCR transgenic mice. Briefly, single-cell suspensions were prepared from spleen and lymph nodes and subject to FACS sorting. Sorted TCR+CD4+ T cells were injected into recipient mice via tail vein in 200 μl HBSS. In some experiments, cells were labeled with CFSE before transfer.
Antibodies and flow cytometry. All mAbs were purchased from BD Biosciences unless otherwise specified, including PE-Cy5–conjugated anti-CD4, anti-Thy1.2, and streptavidin; FITC-conjugated anti-CD8, anti-CD44, anti-CD69, anti-Thy1.2, anti-pSTAT1, and anti-pSTAT3; PE-conjugated anti-Thy1.2, anti–Bcl-xL (Santa Cruz Biotechnology), annexin V, and anti-mouse IgG (SouthernBiotech); and PE-conjugated anti-pAkt, purified anti-Akt (pan), allophycocyanin-conjugated anti–IFN-γ, and purified anti-STAT1 and -STAT3 (Cell Signaling Technology). Flow cytometry data were collected by FACSCanto (BD Biosciences) and then analyzed using FACSDiva (BD Biosciences).
Intracellular staining. To measure IFN-γ production in CD4+ T cells, splenocytes were incubated with 5 μg/ml brefeldin A and 20 μg/ml influenza HA peptide (110SFERFEIFPKE120) for 6 hours at 37°C. After stained with anti-CD4 and anti-Thy1.2, cells were permeabilized with the Cytofix/Cytoperm kit (BD Biosciences), as per the manufacturer’s instructions. Permeabilized cells were subsequently stained with anti–IFN-γ. To study Bcl-xL, total STAT1, STAT3, pSTAT1, and pSTAT3, cells derived from in vitro culture and stimulation or from splenocytes of infected mice were first fixed with 3.7% formaldehyde. Afterward, cells were permeabilized with 90% ethanol, blocked with 3% FBS, and then stained with anti-CD4, anti-Thy1.2, and Bcl-xL, STAT1, STAT3, pSTAT1, or pSTAT3.
T cell culture and stimulation. Polyclonal CD4+ T cells were selected from splenocytes by anti-CD4 microbeads selection (Miltenyi Biotec). To measure total STAT1 and STAT3 and their phosphorylation in vitro, 2 × 105 naive T cells were cultured in RPMI 1640 supplemented with 10% FBS, 2 mM L-glutamine, 100 IU/ml penicillin, 100 IU/ml streptomycin, and 50 μM 2-ME, with or without IL-21 (10 ng/ml) for 1 hour and then were subjected to intracellular staining.
Retroviral transduction of T cells. The pMSCV vectors that encode dominant-negative Akt (pMSCV-dn-Akt) and constitutive Akt (pMSCV-constitutive-Akt) were gifts from Z. Songyang (Baylor College of Medicine, Houston, Texas, USA) (31), whereas the one encoding dominant-negative STAT3 (pMSCV-dn-STAT3) was from D. Link (Washington University, St. Louis, Missouri, USA) (32). After a plasmid DNA transfection with CaCl2, retroviruses were grown in BOSC packaging cells in DMEM medium (Cellgro) with 10% FBS, penicillin, streptomycin, and glutamine. Three days after transfection, the supernatant of cell culture was collected to infect CD4 T cells that had been cultured in the presence of IL-2 (100 U/ml), PMA (40 ng/ml), and ionomycin (500 ng/ml) for 24 hours. Cells were centrifuged at 1,300 g for 2 hours in the presence of 8 g/ml polybrene. Three days after the transduction, GFP-positive cells were used for analysis.
Statistics. All statistical analyses were performed with Graph Prism 6 software. Results are expressed as mean ± SEM. Significance between experimental groups was determined by a 2-tailed Student’s t test. A P value of less than 0.05 was considered to be statistically significant for all results.
Study approval. All animal procedures were approved by the Institutional Animal Care and Use Committee at Duke University, Durham, North Carolina, USA.
Yuqing Yuan designed and performed the study, collected and analyzed data, and prepared the paper. Xiaopei Huang and Yiping Yang designed research, analyzed data, and wrote the paper.
This work was supported by NIH grants CA136934, CA186973, and CA193167 (to Y. Yang).
Address correspondence to: Yiping Yang or Xiaopei Huang, Department of Medicine, Duke University Medical Center, Box 103005, Durham, North Carolina 27710, USA. Phone: 919.668.0932; E-mail: yang0029@mc.duke.edu (Y. Yang). Phone: 919.668.0979; E-mail: huang027@mc.duke.edu (X. Huang).
Conflict of interest: The authors have declared that no conflict of interest exists.
Reference information: JCI Insight. 2017;2(7):e90652. https://doi.org/10.1172/jci.insight.90652.
Electronic publication